Corpus Intelligence IC Memo — MISSOURI RIVER MEDICAL CENTER 2026-04-26 09:39 UTC
IC Memo — MISSOURI RIVER MEDICAL CENTER
Investment Committee Memorandum | MT | 25 beds | Grade C | EBITDA uplift $527K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MISSOURI RIVER MEDICAL CENTER

CCN 271304 | nan, MT | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MISSOURI RIVER MEDICAL CENTER is a 25-bed suburban community hospital in nan, MT with $7.0M in net patient revenue and a -16.8% operating margin. The hospital serves a payer mix of 6.5% Medicare, 0.0% Medicaid, and 93.4% commercial.

Thesis: Turnaround. Our ML models identify $527K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -16.8% to -9.3% (+750bps).

Net Revenue HCRIS$7.0M
Current EBITDA COMPUTED$-1.2M
Operating Margin COMPUTED-16.8%
Occupancy HCRIS75.9%
Revenue / Bed COMPUTED$281K
Net-to-Gross HCRIS95.5%
Distress Probability ML48.6%

2. Market Context & Competitive Position

66
MT Hospitals
-9.6%
State Median Margin
48
Comparable Hospitals

MT has 66 Medicare-certified hospitals with a median operating margin of -9.6%. The target's margin of -16.8% places it below the state median. Among 48 size-comparable peers (12-50 beds), the median margin is -8.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 48 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MISSOURI RIVER MEDICAL CENTER (Target)MT25$7.0M-16.8%
GREAT FALLS CLINIC MEDICAL CENMT20$132.1M21.0%
MARCUS DALY MEMORIAL HOSPITALMT25$107.6M-1.3%
LOGAN HEALTH WHITEFISHMT25$101.8M13.8%
SIDNEY HEALTH CENTERMT25$95.2M-6.3%
NORTHERN MONTANA HOSPITALMT49$93.3M-4.7%
COMMUNITY HOSPITAL OF ANACONDAMT25$89.0M1.3%
LIVINGSTON HEALTHCAREMT25$72.6M-7.1%
HOLY ROSARY HEALTHCAREMT25$67.3M1.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $527K (750bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$148K+210bp18mo
Denial Rate Reduction12.0%6.5%$144K+204bp12mo
Cost to Collect4.5%2.5%$141K+200bp12mo
A/R Days Reduction5200.0%3800.0%$86K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$148K
Denial Rate Reduction
$144K
Cost to Collect
$141K
A/R Days Reduction
$86K
Clean Claim Rate
$10K
Total EBITDA Uplift$527K
Current EBITDA$-1.2M
+ RCM Uplift+$527K
Pro Forma EBITDA$-655K
Current Margin-16.8%
Pro Forma Margin-9.3%
WC Released (1x)$270K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.8M$-2.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.8M$-3.4M0.00x-100.0%
Bull Case9.0x11.0x$-1.6M$-2.2M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.6M$-2.9M0.00x-100.0%
Bear Case11.0x10.0x$-2.0M$-4.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-2.0M$-5.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 48 hospitals with 12-50 beds
  • Same-state prioritization (n=49)
  • Comp margins: P25=-20.8% / P50=-8.3% / P75=-1.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.